Johnson & Johnson Comprehensive Income 2012-2026 | JNJ

Johnson & Johnson comprehensive income for the quarter ending March 31, 2026 was $-14.930B, a 27.16% increase year-over-year.

  • Johnson & Johnson comprehensive income for 2025 was $-14.93B, a 27.16% increase from 2024.
  • Johnson & Johnson comprehensive income for 2024 was $-11.741B, a 6.27% decline from 2023.
  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.

Johnson & Johnson Comprehensive Income 2012-2026 | JNJ

  • Johnson & Johnson comprehensive income for 2025 was $-14.93B, a 27.16% increase from 2024.
  • Johnson & Johnson comprehensive income for 2024 was $-11.741B, a 6.27% decline from 2023.
  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B